| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 759.3 | 496.6 |
| Net income | 6.4 | -24.4 |
| EPS (diluted, $ a share) | $0.01 | $-0.05 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +52.9% |
|---|---|
| Operating margin | 0.8% |
10-Q filed with the SEC, NASDAQ: CLOV. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Clover Health Investments, Corp.: key numbers
- Share price
- $4.73Close, Nov 17
- Sector
- Finance
- Industry
- Hospital & Medical Service PlansSIC 6324
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Clover Health Investments, Corp.
All →Clover Health Investments Business Update
Clover Health published a supplemental Q&A document to address frequently asked shareholder questions following its third quarter 2026 earnings announcement. The update discusses long-term projections through 2028, membership cohort maturation, and plans to improve the company's Adjusted SG&A ratio through operating leverage as it scales.
Clover Health Investments Financial Results
Clover Health reported Q3 2026 financial results, achieving GAAP net income of $6 million and total revenue growth of 53% year-over-year to $759.3 million. The company raised its full-year 2026 guidance, now expecting total revenues between $2.97 billion and $3.00 billion and its first full year of GAAP net income profitability. Alongside the results, the company appointed Interim CFO Joseph Clay Thornton to the role on a permanent basis.
- Term
- Q3 2026
“Our results further demonstrate our technology-powered differentiation, and how earlier and better care management, market-leading growth, and increasing profitability can reinforce one another under the right model.”
Andrew Toy, Clover Health CEO
“In 2026, Clover is on track to have grown significantly and expects to deliver its first full year of GAAP Net Income profitability. With our largest member cohorts maturing, continued operating leverage, and strong Star ratings performance, we believe we are well positioned for meaningful earnings expansion in 2027.”
Clay Thornton, Clover Health CFO
Clover Health Investments CLO Karen Soares Sells $89.8K of Stock
Karen Soares, CLO, sold 19,275 shares of Clover Health Investments, Corp. at $4.66 a share, worth $89.8K in total on Oct 20, 2026. Shares held after the trade: 1,573,423 (-1.2%).
- Value
- $89.8K
- Shares
- 19,275
- Price
- $4.66
- Role
- CLO
- Holding change
- -1.2%
- Trade date
- Oct 20, 2026
Clover Health Investments CEO, Medicare Advantage Jamie L. Reynoso Sells $17.9K of Stock
Jamie L. Reynoso, CEO, Medicare Advantage, sold 4,066 shares of Clover Health Investments, Corp. at $4.41 a share, worth $17.9K in total on Oct 19, 2026. Shares held after the trade: 2,770,351 (-0.1%).
- Value
- $17.9K
- Shares
- 4,066
- Price
- $4.41
- Role
- CEO, Medicare Advantage
- Holding change
- -0.1%
- Trade date
- Oct 19, 2026
Clover Health Investments CEO Andrew Toy Sells $291K of Stock
Andrew Toy, CEO, sold 62,176 shares of Clover Health Investments, Corp. at $4.68 a share, worth $291K in total on Oct 15, 2026. Shares held after the trade: 9,078,334 (-0.7%).
- Value
- $291K
- Shares
- 62,176
- Price
- $4.68
- Role
- CEO
- Holding change
- -0.7%
- Trade date
- Oct 15, 2026
Clover Health Investments CLO Karen Soares Sells $68.7K of Stock
Karen Soares, CLO, sold 14,673 shares of Clover Health Investments, Corp. at $4.68 a share, worth $68.7K in total on Oct 15, 2026. Shares held after the trade: 1,592,698 (-0.9%).
- Value
- $68.7K
- Shares
- 14,673
- Price
- $4.68
- Role
- CLO
- Holding change
- -0.9%
- Trade date
- Oct 15, 2026